Fa
فارسی
Ca
Canada/HealthBulance
Home
About
Vision
Mission
Services
Payments
Contact Us
WHO Org:
more read ...
WHO urges rapid access to mpox diagnostic tests, invites manufacturers to emergency review
WHO has asked manufacturers of mpox in vitro diagnostics (IVDs) to submit an expression of interest for Emergency Use Listing (EUL). WHO has been in ongoing discussions with manufacturers about the need for effective diagnostics, particularly in low-income settings. The request for EUL expressions of interest by manufacturers is the latest development in these discussions.
9/5/2024 1:57:08 AM
Related Topics
WHO Org:
more ...
WHO invites mpox vaccine manufacturers to submit dossiers for emergency evaluation
WHO has today issued an invitation for manufacturers of mpox vaccines to submit an Expression of Interest for Emergency Use Listing (EUL).
WHO Org:
more ...
Statement of the Thirty-ninth Meeting of the Polio IHR Emergency Committee
WHO Org:
more ...
First meeting of the International Health Regulations (2005) Emergency Committee regarding the upsurge of mpox 2024
The Director-General of the World Health Organization (WHO), having concurred with the advice offered by the International Health Regulations (2005) (IHR or Regulations) Emergency Committee regarding the upsurge of mpox 2024 during its first meeting, held on 14 August 2024, has determined, on the same date, that the ongoing upsurge of mpox in the Democratic Republic of the Congo (DRC) and in a growing number of countries in Africa constitutes a public health emergency of international concern (PHEIC) under the provisions of the Regulations. The communication of the Director-General regarding the determination of the above-mentioned PHEIC on 14 August 2024 is available here.
